Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Kunli Pharmaceutical is a specialized manufacturer of high-end pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs) based in Nantong, China. The company leverages advanced expertise in chiral synthesis and nucleoside chemistry to support the development of complex small molecule therapeutics. As a Contract Development and Manufacturing Organization (CDMO), Kunli serves global pharmaceutical clients across therapeutic areas including oncology, antiviral, and cardiovascular medicine. The firm is recognized for its commitment to green chemistry and maintains production facilities that adhere to international regulatory standards. Their R&D capabilities are centered on providing cost-effective and scalable solutions for challenging chemical transformations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Kunli.